BR0009862A - Composição tópica para tratar glaucoma ou hipertensão ocular, e, método para tratar glaucoma ou hipertensão ocular - Google Patents

Composição tópica para tratar glaucoma ou hipertensão ocular, e, método para tratar glaucoma ou hipertensão ocular

Info

Publication number
BR0009862A
BR0009862A BR0009862-0A BR0009862A BR0009862A BR 0009862 A BR0009862 A BR 0009862A BR 0009862 A BR0009862 A BR 0009862A BR 0009862 A BR0009862 A BR 0009862A
Authority
BR
Brazil
Prior art keywords
ocular hypertension
treating glaucoma
topical composition
glaucoma
treating
Prior art date
Application number
BR0009862-0A
Other languages
English (en)
Inventor
Debra L Shade
Iok-Hou Pang
Abbot F Clark
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of BR0009862A publication Critical patent/BR0009862A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO TóPICA PARA TRATAR GLAUCOMA OU HIPERTENSãO OCULAR, E, MéTODO PARA TRATAR GLAUCOMA OU HIPERTENSãO OCULAR". São descritas composições compreendendo ativadores AP-1 e métodos de uso para tratar glaucoma e hipertensão ocular.
BR0009862-0A 1999-04-20 2000-04-07 Composição tópica para tratar glaucoma ou hipertensão ocular, e, método para tratar glaucoma ou hipertensão ocular BR0009862A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13013399P 1999-04-20 1999-04-20
PCT/US2000/009503 WO2000062769A2 (en) 1999-04-20 2000-04-07 Use of ap-1 activators to treat glaucoma and ocular hypertension

Publications (1)

Publication Number Publication Date
BR0009862A true BR0009862A (pt) 2002-01-08

Family

ID=22443214

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009862-0A BR0009862A (pt) 1999-04-20 2000-04-07 Composição tópica para tratar glaucoma ou hipertensão ocular, e, método para tratar glaucoma ou hipertensão ocular

Country Status (12)

Country Link
EP (1) EP1169026B1 (pt)
JP (1) JP2002542189A (pt)
AT (1) ATE270883T1 (pt)
AU (1) AU766199B2 (pt)
BR (1) BR0009862A (pt)
CA (1) CA2369126A1 (pt)
DE (1) DE60012163T2 (pt)
DK (1) DK1169026T3 (pt)
ES (1) ES2223502T3 (pt)
HK (1) HK1039568B (pt)
PT (1) PT1169026E (pt)
WO (1) WO2000062769A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000851A2 (en) * 2008-07-04 2010-01-07 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for modulating angiogenesis via dystrophin dp71

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CN1169857A (zh) * 1996-07-10 1998-01-14 林东和 降眼压活性组合物

Also Published As

Publication number Publication date
DE60012163T2 (de) 2004-11-11
ES2223502T3 (es) 2005-03-01
DK1169026T3 (da) 2004-10-04
DE60012163D1 (de) 2004-08-19
EP1169026B1 (en) 2004-07-14
PT1169026E (pt) 2004-10-29
JP2002542189A (ja) 2002-12-10
HK1039568A1 (en) 2002-05-03
AU4223100A (en) 2000-11-02
ATE270883T1 (de) 2004-07-15
WO2000062769A2 (en) 2000-10-26
WO2000062769A3 (en) 2001-01-04
AU766199B2 (en) 2003-10-09
EP1169026A2 (en) 2002-01-09
HK1039568B (zh) 2004-12-10
CA2369126A1 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
BR9813684A (pt) Processo para tratar o glaucoma glc1a, e, composição para controlar o glaucoma glc1a.
BR9913800A (pt) Método para tratar glaucoma, e, composição para tratar glaucoma
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
DE69725825D1 (de) 5-HT1F-Agonisten
AU2002213336A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
DE69728585D1 (de) Mittel gegen Juckreiz
NO983189L (no) Nye substituerte imidazolforbindelser
AR023777A1 (es) Nuevos compuestos
DE69725153D1 (de) Kaliumkanal-blocker
AR038563A1 (es) Composicion de ziprasidona y controles sinteticos
ATE322258T1 (de) Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren
ATE288747T1 (de) Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
TR199701669A1 (xx) Deri preparasyonu i�in bile�imler.
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
BR0317461A (pt) Composições tópicas absorventes de óleo e método para o uso das mesmas
DE60237003D1 (de) Verwendung von 3-positions-cyclosporin-derivaten für haarwachstum
WO2001015677A3 (en) Use of 5-ht1b/1d agonists to treat otic pain
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO2002041831A3 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
BR0009862A (pt) Composição tópica para tratar glaucoma ou hipertensão ocular, e, método para tratar glaucoma ou hipertensão ocular
BR0111785A (pt) Composições e métodos para tratamento de candidìase
NO20002408D0 (no) 5-HT1F antagonister

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ALCON MANUFACTURING, LTD. (US)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.